Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies

Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies

Background: Association between plasma pentraxin-3 (PTX-3) and clinical outcomes in patients with coronary artery disease (CAD) remains not fully determined. An updated meta-analysis of cohort studies was performed to systematically evaluate the association.Methods: Cohort studies evaluating the ass...

Full description

Bibliographic Details
Main Authors: Kejun Ding, Zhewei Shi, Caizhen Qian, Xuan Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
coronary artery disease
mortality
major adverse cardiovascular events
pentraxin-3
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.726289/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.726289/full

Similar Items